Loading...
Is metastatic pancreatic cancer an untargetable malignancy?
Metastatic pancreatic cancer (MPC) is one of the most aggressive malignancies, known to be chemo-resistant and have been recently considered resistant to some targeted therapies (TT). Erlotinib combined to gemcitabine is the only targeted therapy that showed an overall survival benefit in MPC. New t...
Na minha lista:
| Udgivet i: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4789615/ https://ncbi.nlm.nih.gov/pubmed/26989465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v8.i3.297 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|